|
|
|
|
|
|
|
|
|
29.10.26 - 14:04
|
Elicio Therapeutics to Present Phase 2 AMPLIFY-7P Results at the SITC 2026 Annual Meeting (GlobeNewswire EN)
|
|
|
BOSTON, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that the Company will conduct a keynote/plenary presentation, as well as two poster presentations showcasing additional results from the randomized Phase 2 AMPLIFY-7P study of camupepimut (ELI-002 7P) and an expanded antigen-agnostic intratumoral application of the AMP-adjuvant platform at the Society for Immunotherapy of Cancer's (“SITC”) Annual Meeting. The meeting will take place November 4-8, 2026 in Phoenix, Arizona....
|
|
|
|
|
29.10.26 - 14:01
|
Candel Therapeutics Announces Late-Breaking Abstract Accepted for Poster Presentation at the SITC 2026 Annual Meeting, Featuring Aglatimagene Besadenovec Data in Localized Prostate Cancer (GlobeNewswire EN)
|
|
|
NEEDHAM, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced that a late-breaking abstract from its phase 2 PrTK05 clinical trial evaluating aglatimagene besadenovec (aglatimagene) in localized prostate cancer has been accepted for poster presentation at the Society for Immunotherapy of Cancer's (SITC) 41st Annual Meeting, taking place November 4–8, 2026, in Phoenix, Arizona....
|
|
|
|
|
29.10.26 - 10:45
|
Results: QHD PORT 9M Net Profit Rises 0.42% YoY to RMB1.396B (AAStocks)
|
|
|
QHD PORT (03369.HK) announced its results for the first three quarters ended September 2026. Revenue was RMB5.303 billion, up 1.75% YoY. Net profit increased 0.42% YoY to RMB1.396 billion, while EPS was RMB0.25. (ad/)~AASTOCKS Financial NewsWebsite: www.aastocks.comThis article was automatically translated by AI, the Chinese ver......
|
|
|
29.10.26 - 10:15
|
Results: QINGDAO PORT 1Q-3Q Net Profit RMB4.15B (AAStocks)
|
|
|
QINGDAO PORT (06198.HK) announced its results for the first three quarters ended September 2026. Revenue was RMB15.474 billion, up 8.68% YoY. Net profit was RMB4.149 billion, down 0.76% YoY. EPS was RMB0.64. (su)~AASTOCKS Financial NewsWebsite: www.aastocks.comThis article was automatically translated by AI, the Chinese version ......
|
|
|
|
|
|
|
|
|
|
|
28.10.26 - 05:30
|
ZTO EXPRESS-W Repurchases 79,300 ADRs on Tue for USD1.5832 million (AAStocks)
|
|
|
ZTO EXPRESS-W (02057.HK) announced that it repurchased 79,300 ADRs of ZTO Express (Cayman) Inc. (ZTO.US) on the New York Stock Exchange on Tuesday (27th), at prices ranging from USD19.89 to USD19.99 per share, involving approximately USD1.5832 million.Since the repurchase authorization resolution was approved, the group has cumu......
|
|
|
|
|
28.10.26 - 02:30
|
Results: JIANGSU EXPRESS 9M Net Profit RMB3.853B, Up 0.42% YoY (AAStocks)
|
|
|
JIANGSU EXPRESS (00177.HK) announced its results for the first three quarters ended September 2026. Revenue rose 18.6% YoY to RMB15.396 billion. Net profit increased 0.42% YoY to RMB3.853 billion, while EPS was RMB0.7649. (jl)~AASTOCKS Financial NewsWebsite: www.aastocks.comThis article was automatically translated by AI, the Ch......
|
|
|
27.10.26 - 12:30
|
Results: SINOTRANS 9M Net Profit Slips 0.12% YoY to RMB2.676B (AAStocks)
|
|
|
SINOTRANS (00598.HK) announced its results for the first three quarters ended September 2026. Revenue was RMB71.987 billion, down 4.07% YoY. Net profit was RMB2.676 billion, down 0.12% YoY. EPS was RMB0.373.For 3Q alone, revenue was RMB25.534 billion, up 4.16% YoY. Net profit was RMB951 million, up 29.88% YoY. EPS was RMB0.1326.......
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
